Enliven Therapeutics Inc (ELVN)
followers
·
Follow
| Sector: | HEALTH CARE |
| Industry: | BIOTECHNOLOGY & LIFE SCIENCES |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Samuel S. Kintz |
| Employees: | |
| Web site: | www.enliventherapeutics.com |
|
6200 LOOKOUT ROAD, BOULDER, CO, 80301
720-647-8519
| |
Are you looking for these stocks instead?
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial has been activated to evaluate people with cancers harboring an abnormal HER2 gene. The company is based in Boulder, Colorado.
Please log in first to see chart